Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Sending National Guard to Washington could slow U.S. vaccine hand out

Published 12/01/2021, 03:28
Updated 12/01/2021, 03:30
© Reuters. Members Of New York Police Department Receive Covid-19 Vaccine

By Richard Cowan

WASHINGTON (Reuters) - The need to divert National Guard troops to Washington to provide security for next week's inauguration of President-elect Joe Biden could hinder the distribution of coronavirus vaccines in various U.S. states, a Democratic lawmaker said on Monday.

Washington is reeling from the Jan. 6 attack on the U.S. Capitol by supporters of President Donald Trump and authorities are working to head off possible civil unrest during Biden's Jan. 20 swearing-in at the Capitol.

As many as 15,000 National Guard troops have been authorized to be sent to Washington.

Democratic Representative Tim Ryan, who chairs a House committee that oversees the U.S. Capitol Police and security around the Capitol, said that National Guard troops could also be dispatched to several state capitals amid reports that Trump supporters will be staging protests around the nation next week.

Ryan said he spoke with National Guard officials on Monday and was told that the huge new demands on the troops could strain some operations.

"The vaccine issue (distribution) would be affected by this. That's just food for thought about the ripple effect happening because of what we're dealing with in Washington," Ryan told reporters.

"It will probably take away from some of the vaccine distribution in some of the states if we call on them" to come to Washington," Ryan said.

Some states have been using the National Guard to help distribute coronavirus vaccines to cities and towns as they ramp up an effort to vaccinate up to 300 million people in the United States.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The country has registered more than 22.6 million cases of COVID-19, the deadly illness caused by the coronavirus. Nearly 376,000 people in the United States have died, with no sign yet of the pandemic subsiding.

About 9 million people have received the first of two doses of the vaccine, far below the 20 million by the end of 2020 that the Trump administration had projected.

Biden has criticized the slow pace of vaccination and said he wanted 100 million Americans vaccinated in the first 100 days of his administration starting on Jan. 20.

Ryan did not provide details on how many people might have to delay getting vaccinated if National Guard troops from various states come to Washington.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.